The introduction of 750mcg teriparatide injection in Australia has involved significant distribution . Currently, it’s primarily offered for patients with severe osteoporosis who other therapies have not been effective. Securing this stronger formulation presents as difficult due to specialist prescription requirements and limited hospital stock… Read More